Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 39: 218-223, 1993;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henderson, A. D.
Right arrow Articles by Elkeles, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henderson, A. D.
Right arrow Articles by Elkeles, R. S.

Clinical Chemistry, Vol 39, 218-223, Copyright © 1993 by American Association for Clinical Chemistry

Hepatic and lipoprotein lipases selectively assayed in postheparin plasma

AD Henderson, W Richmond and RS Elkeles
Unit of Metabolic Medicine, St. Mary's Hospital Medical School, Imperial College of Science, Technology and Medicine, London, UK.

Sensitive, reliable procedures are reported for the selective assay of lipoprotein lipase (LPL) and hepatic lipase (HL) in postheparin plasma samples. LPL is inhibited in the HL assay by inclusion of 0.76 mol/L sodium chloride in the substrate. In the LPL assay, specificity is attained by pretreating the sample with sodium dodecyl sulfate, which selectively denatures HL. This LPL method was validated by direct comparison with a procedure in which HL is inactivated by an antiserum to human HL. We used the described assays to quantify LPL and HL activity in 32 normal adults, demonstrating a clear sex difference for both enzymes. On average, the men displayed higher HL and lower LPL activities than did the women.


The following articles in journals at HighWire Press have cited this article:


Home page
EndocrinologyHome page
A. Koster, Y. B. Chao, M. Mosior, A. Ford, P. A. Gonzalez-DeWhitt, J. E. Hale, D. Li, Y. Qiu, C. C. Fraser, D. D. Yang, et al.
Transgenic Angiopoietin-Like (Angptl)4 Overexpression and Targeted Disruption of Angptl4 and Angptl3: Regulation of Triglyceride Metabolism
Endocrinology, November 1, 2005; 146(11): 4943 - 4950.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. Cabre, J. M Hernandez-Perez, L. Fluvia, C. Pastor, A. Corominas, and M. A Gassull
Absorption and transport of dietary long-chain fatty acids in cirrhosis: a stable-isotope-tracing study
Am. J. Clinical Nutrition, March 1, 2005; 81(3): 692 - 701.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Frénais, H. Nazih, K. Ouguerram, C. Maugeais, Y. Zaïr, J. M. Bard, B. Charbonnel, T. Magot, and M. Krempf
In Vivo Evidence for the Role of Lipoprotein Lipase Activity in the Regulation of Apolipoprotein AI Metabolism: A Kinetic Study in Control Subjects and Patients with Type II Diabetes Mellitus
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1962 - 1967.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Tailleux, M. Bouly, G. Luc, G. Castro, J.-M. Caillaud, N. Hennuyer, P. Poulain, J.-C. Fruchart, N. Duverger, and C. Fievet
Decreased Susceptibility to Diet-Induced Atherosclerosis in Human Apolipoprotein A-II Transgenic Mice
Arterioscler Thromb Vasc Biol, November 1, 2000; 20(11): 2453 - 2458.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Bouly, D. Masson, B. Gross, X.-c. Jiang, C. Fievet, G. Castro, A. R. Tall, J.-C. Fruchart, B. Staels, L. Lagrost, et al.
Induction of the Phospholipid Transfer Protein Gene Accounts for the High Density Lipoprotein Enlargement in Mice Treated with Fenofibrate
J. Biol. Chem., July 6, 2001; 276(28): 25841 - 25847.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Association for Clinical Chemistry.